Sorrento Therapeutics, Inc. — Form D
Sorrento Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-06-19. The offering totals $2.3M, of which $2.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-06-19
- Form: D
- Accession: 0001466679-09-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.3M
- Amount sold: $2.3M
- Investors: 1
- Date of first sale: 2009-06-10
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-132103
Issuer
- Name: Sorrento Therapeutics, Inc.
- CIK: 0001466679
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2006
- Address: 10054 MESA RIDGE COURT, SUITE 122, SAN DIEGO, CA, 92121
- Phone: 858.205.4193
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Henry Ji | Director | Palo Alto, CA |
| Antonius Schuh | Director | San Diego, CA |
| Steve Zaniboni | Director | San Diego, CA |
| Henry Ji | Executive Officer | Palo Alto, CA |
| Antonius Schuh | Executive Officer | San Diego, CA |
| Steve Zaniboni | Executive Officer | San Diego, CA |
More